BACKGROUND: Red blood cell (RBC) rheology is altered in different diseases, including acute conditions such as patients in intensive care units (ICU) with sepsis or with an inflammatory reaction due to postoperative states or intracerebral haemorrhage, or chronic conditions such as diabetes mellitus or terminal renal failure. Several techniques are available to assess alterations in RBC rheology, especially deformability, but they are too cumbersome to be used on a large number of cells. OBJECTIVE: To develop a new, rapid flow cytometry technique for easy assessment of RBC shape in patients. METHODS: In flow cytometry, healthy human RBC shape shows a bimodal distribution related to the biconcave form. On this histogram, the second Pearson coefficient of dissymmetry (PCD) representing the asymmetry of this histogram and the spherical index (M2:M1) were calculated, both representing the spherical shape. This technique was used in healthy volunteers (n=17) and in diseases characterised by abnormalities in RBC rheology, including terminal renal failure requiring haemodialysis (n=28), diabetes mellitus (n=18), sepsis (n=19) and acute inflammatory states (postoperative, intracerebral haemorrhage, chronic obstructive pulmonary disease, epilepsy or severe drug intoxication; n=21). Multivariate analysis was performed to determine the factors influencing RBC shape. RESULTS: Measurement of RBC shape was highly reproducible. A good correlation was observed between the PCD and the spherical index, except in the critically ill patients without sepsis. RBCs were more spherical in patients with terminal renal failure (PCD -0.56 (0.14), p<0.05), diabetes mellitus (PCD -0.59 (0.23), p<0.05), sepsis (PCD -0.58 (0.22), p<0.05) or an acute inflammatory state (PCD -0.65 (0.29), p<0.05) than in healthy volunteers (PCD -0.89 (0.12)). The spherical index was also increased in all populations compared with healthy volunteers (terminal renal failure 2.30 (0.20); diabetes mellitus 2.27 (0.38); sepsis 2.28 (0.37); acute inflammatory state 2.35 (0.42) vs healthy volunteers 2.72 (0.47); all p<0.05). Multivariate analysis demonstrated that the underlying pathology (sepsis, acute inflammatory state, diabetes mellitus, terminal renal failure) was the principal cause of these RBC shape abnormalities. CONCLUSION: RBCs are characterised by an increased spherical shape in many disease states. The measure of the second PCD in flow cytometry is a new, easy method to investigate RBC shape in various diseases. This technique could facilitate the investigation of abnormalities of RBC rheology.
BACKGROUND: Red blood cell (RBC) rheology is altered in different diseases, including acute conditions such as patients in intensive care units (ICU) with sepsis or with an inflammatory reaction due to postoperative states or intracerebral haemorrhage, or chronic conditions such as diabetes mellitus or terminal renal failure. Several techniques are available to assess alterations in RBC rheology, especially deformability, but they are too cumbersome to be used on a large number of cells. OBJECTIVE: To develop a new, rapid flow cytometry technique for easy assessment of RBC shape in patients. METHODS: In flow cytometry, healthy human RBC shape shows a bimodal distribution related to the biconcave form. On this histogram, the second Pearson coefficient of dissymmetry (PCD) representing the asymmetry of this histogram and the spherical index (M2:M1) were calculated, both representing the spherical shape. This technique was used in healthy volunteers (n=17) and in diseases characterised by abnormalities in RBC rheology, including terminal renal failure requiring haemodialysis (n=28), diabetes mellitus (n=18), sepsis (n=19) and acute inflammatory states (postoperative, intracerebral haemorrhage, chronic obstructive pulmonary disease, epilepsy or severe drug intoxication; n=21). Multivariate analysis was performed to determine the factors influencing RBC shape. RESULTS: Measurement of RBC shape was highly reproducible. A good correlation was observed between the PCD and the spherical index, except in the critically illpatients without sepsis. RBCs were more spherical in patients with terminal renal failure (PCD -0.56 (0.14), p<0.05), diabetes mellitus (PCD -0.59 (0.23), p<0.05), sepsis (PCD -0.58 (0.22), p<0.05) or an acute inflammatory state (PCD -0.65 (0.29), p<0.05) than in healthy volunteers (PCD -0.89 (0.12)). The spherical index was also increased in all populations compared with healthy volunteers (terminal renal failure 2.30 (0.20); diabetes mellitus 2.27 (0.38); sepsis 2.28 (0.37); acute inflammatory state 2.35 (0.42) vs healthy volunteers 2.72 (0.47); all p<0.05). Multivariate analysis demonstrated that the underlying pathology (sepsis, acute inflammatory state, diabetes mellitus, terminal renal failure) was the principal cause of these RBC shape abnormalities. CONCLUSION: RBCs are characterised by an increased spherical shape in many disease states. The measure of the second PCD in flow cytometry is a new, easy method to investigate RBC shape in various diseases. This technique could facilitate the investigation of abnormalities of RBC rheology.
Authors: Daniel De Backer; Jacques Creteur; Jean-Charles Preiser; Marc-Jacques Dubois; Jean-Louis Vincent Journal: Am J Respir Crit Care Med Date: 2002-07-01 Impact factor: 21.405
Authors: M Piagnerelli; K Zouaoui Boudjeltia; P Piro; D Brohee; M Vanhaeverbeek; J L Vincent Journal: Clin Hemorheol Microcirc Date: 2004 Impact factor: 2.375
Authors: Mitchell M Levy; Mitchell P Fink; John C Marshall; Edward Abraham; Derek Angus; Deborah Cook; Jonathan Cohen; Steven M Opal; Jean-Louis Vincent; Graham Ramsay Journal: Crit Care Med Date: 2003-04 Impact factor: 7.598
Authors: Michael Piagnerelli; Karim Zouaoui Boudjeltia; Danny Brohee; Pietrina Piro; Eric Carlier; Jean-Louis Vincent; Philippe Lejeune; Michel Vanhaeverbeek Journal: Crit Care Med Date: 2003-08 Impact factor: 7.598
Authors: J G G Dobbe; M R Hardeman; G J Streekstra; J Strackee; C Ince; C A Grimbergen Journal: Blood Cells Mol Dis Date: 2002 May-Jun Impact factor: 3.039
Authors: M G Della Porta; L Malcovati; R Invernizzi; E Travaglino; C Pascutto; M Maffioli; A Gallì; S Boggi; D Pietra; L Vanelli; C Marseglia; S Levi; P Arosio; M Lazzarino; M Cazzola Journal: Leukemia Date: 2006-04 Impact factor: 11.528
Authors: María Belén Jiménez-Díaz; Daniel Ebert; Yandira Salinas; Anupam Pradhan; Adele M Lehane; Marie-Eve Myrand-Lapierre; Kathleen G O'Loughlin; David M Shackleford; Mariana Justino de Almeida; Angela K Carrillo; Julie A Clark; Adelaide S M Dennis; Jonathon Diep; Xiaoyan Deng; Sandra Duffy; Aaron N Endsley; Greg Fedewa; W Armand Guiguemde; María G Gómez; Gloria Holbrook; Jeremy Horst; Charles C Kim; Jian Liu; Marcus C S Lee; Amy Matheny; María Santos Martínez; Gregory Miller; Ane Rodríguez-Alejandre; Laura Sanz; Martina Sigal; Natalie J Spillman; Philip D Stein; Zheng Wang; Fangyi Zhu; David Waterson; Spencer Knapp; Anang Shelat; Vicky M Avery; David A Fidock; Francisco-Javier Gamo; Susan A Charman; Jon C Mirsalis; Hongshen Ma; Santiago Ferrer; Kiaran Kirk; Iñigo Angulo-Barturen; Dennis E Kyle; Joseph L DeRisi; David M Floyd; R Kiplin Guy Journal: Proc Natl Acad Sci U S A Date: 2014-12-01 Impact factor: 11.205
Authors: L-Ruth Montes; David J López; Jesús Sot; Luis A Bagatolli; Martin J Stonehouse; Michael L Vasil; Bill X Wu; Yusuf A Hannun; Félix M Goñi; Alicia Alonso Journal: Biochemistry Date: 2008-10-01 Impact factor: 3.162
Authors: Christoph Ahlgrim; Torben Pottgiesser; Thomas Sander; Yorck Olaf Schumacher; Manfred W Baumstark Journal: PLoS One Date: 2013-03-21 Impact factor: 3.240